HORIBA ABX Diagnostics has announced availability of their new Pentra 400 Benchtop Clinical Chemistry System with workflow optimization in mind! This innovative design re-introduces the benchtop, small footprint concept targeted for low-to-moderate volume laboratories and as a backup alternative for high-volume esoteric testing. The Pentra 400 delivers simplified QC and patient data management with touch screen capability. Quality results are produced from precision analysis of up to 420 tests/hr. utilizing a well-designed combination of 52 on-board reagent positions. The Pentra 400 incorporates optical holographic grating technology that yields the highest quality of measurement – delivering your BMP panel in less than 7.5 minutes! This flexible analyzer delivers continuous loading capabilities, automatic sample dilution, and rules-based results validation - all engineered to simplify the sampling process and enhance lab productivity.
Recognized in over 140 countries across 5 continents, HORIBA ABX joins efforts with 38 companies of varying strengths in developing semiconductor, analytical and measurement systems demonstrate our perpetual strive for excellence. IVD Technology has published HORIBA ABX as the 5th highest-growth IVD manufacturer with average revenue increases exceeding 50%; therefore, maintaining position as a recognized worldwide leader in the manufacturing of quality hematology and chemistry instrumentation.